Efficacy and Safety of Once‐Weekly Semaglutide 2.0 mg as an Add‐On to Dose‐Reduced Insulin Glargine versus Dose‐Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight ( SUSTAIN OPTIMIZE )

Diabetes, Obesity and Metabolism · Published 2026-07-26 · DOI 10.1111/dom.71132

Free full text

Authors (8)

Helena W. Rodbard, Concetta Irace, Jevitha Lobo, Konstantinos Makrilakis, Prachi Priyadarshini, Suvanjaa Sivalingam, Santiago Tofé Povedano, Anuj Bhargava

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Rodbard, H., Irace, C., Lobo, J., et al. (2026). Efficacy and Safety of Once‐Weekly Semaglutide 2.0 mg as an Add‐On to Dose‐Reduced Insulin Glargine versus Dose‐Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight ( SUSTAIN OPTIMIZE ). Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71132

Related articles